ArticleEuropean radiology2026
A deep learning model to reduce agent dose for contrast-enhanced MRI of the cerebellopontine angle cistern.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesTo evaluate a deep learning (DL) model for reducing the agent dose of contrast-enhanced T1-weighted MRI (T1ce) of the cerebellopontine angle (CPA) cistern. MATERIALS AND
methodsIn this multicenter retrospective study, T1 and T1ce of vestibular schwannoma (VS) patients were used to simulate low-dose T1ce with varying reductions of contrast agent dose. DL models were trained to restore standard-dose T1ce from the low-dose simulation. The image quality and segmentation performance of the DL-restored T1ce were evaluated. A head and neck radiologist was asked to rate DL-restored images in multiple aspects, including image quality and diagnostic characterization.
results203 MRI studies from 72 VS patients (mean age, 58.51 ± 14.73, 39 men) were evaluated. As the input dose increased, the structural similarity index measure of the restored T1ce increased from 0.639 ± 0.113 to 0.993 ± 0.009, and the peak signal-to-noise ratio increased from 21.6 ± 3.73 dB to 41.4 ± 4.84 dB. At a 10% input dose, using DL-restored T1ce for segmentation improved the Dice from 0.673 to 0.734, the 95% Hausdorff distance from 2.38 mm to 2.07 mm, and the average surface distance from 1.00 mm to 0.59 mm. Both DL-restored T1ce from 10% and 30% input doses showed excellent image quality (3, interquartile range (IQR) [Q3-Q1] = 3-3 and 3, IQR [Q3-Q1] = 4-3), with the latter being considered more informative (4, IQR [Q3-Q1] = 4-3).
conclusionThe DL model improved the image quality of low-dose MRI of the CPA cistern, which makes lesion detection and diagnostic characterization possible with 10-30% of the standard dose. KEY POINTS: Question Deep learning models that aid in the reduction of contrast agent dose are not extensively evaluated for MRI of the cerebellopontine angle cistern. Findings Deep learning models restored the low-dose MRI of the cerebellopontine angle cistern, yielding images sufficient for vestibular schwannoma diagnosis and management. Clinical relevance Deep learning models make it possible to reduce the use of gadolinium-based contrast agents for contrast-enhanced MRI of the cerebellopontine angle cistern.
Indexed as
Identifiers
41329327What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.